• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内胆管细胞癌的超声造影:与病理检查的相关性。

Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination.

机构信息

Department of Medical Ultrasound, Tenth People's Hospital of Tongji University & Shanghai Tenth People's Hospital, Medical Imaging Center of Tongji University, Shanghai, China.

出版信息

Br J Radiol. 2012 Aug;85(1016):1029-37. doi: 10.1259/bjr/21653786. Epub 2012 Feb 28.

DOI:10.1259/bjr/21653786
PMID:22374276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3587094/
Abstract

OBJECTIVE

To investigate the correlation between enhancement patterns of intrahepatic cholangiocarcinoma (ICC) on contrast-enhanced ultrasound (CEUS) and pathological findings.

METHODS

The CEUS enhancement patterns of 40 pathologically proven ICC lesions were retrospectively analysed. Pathologically, the degree of tumour cell and fibrosis distribution in the lesion was semi-quantitatively evaluated.

RESULTS

4 enhancement patterns were observed in the arterial phase for 32 mass-forming ICCs: peripheral rim-like hyperenhancement (n=19); heterogeneous hyperenhancement (n=6); homogeneous hyperenhancement (n=3); and heterogeneous hypo-enhancement (n=4). Among the four enhancement patterns, the differences in tumour cell distribution were statistically significant (p<0.05). The hyperenhancing area on CEUS corresponded to more tumour cells for mass-forming ICCs. Heterogeneous hyperenhancement (n=2) and heterogeneous hypo-enhancement (n=2) were observed in the arterial phase for four periductal infiltrating ICCs. In this subtype, fibrosis was more commonly found in the lesions. Heterogeneous hyperenhancement (n=1) and homogeneous hyperenhancement (n=3) were observed in the arterial phase for four intraductal growing ICCs. This subtype tended to have abundant tumour cells.

CONCLUSION

The CEUS findings of ICC relate to the degree of carcinoma cell proliferation at pathological examination. Hyperenhancing areas in the tumour always indicated increased density of cancer cells.

摘要

目的

探讨肝内胆管癌(ICC)在超声造影(CEUS)增强模式与病理表现之间的相关性。

方法

回顾性分析 40 例经病理证实的 ICC 病变的 CEUS 增强模式。病理上,对病变中肿瘤细胞和纤维化分布程度进行半定量评估。

结果

32 例肿块型 ICC 在动脉期观察到 4 种增强模式:周边环形高增强(n=19);不均匀高增强(n=6);均匀高增强(n=3);不均匀低增强(n=4)。在这四种增强模式中,肿瘤细胞分布的差异具有统计学意义(p<0.05)。CEUS 上的高增强区域对应于更多的肿瘤细胞。4 例沿胆管浸润型 ICC 在动脉期呈不均匀高增强(n=2)和不均匀低增强(n=2)。在这种亚型中,病变中更常见纤维化。4 例沿胆管生长型 ICC 在动脉期呈不均匀高增强(n=1)和均匀高增强(n=3)。该亚型倾向于具有丰富的肿瘤细胞。

结论

ICC 的 CEUS 表现与病理检查中癌细胞增殖程度有关。肿瘤的高增强区域总是提示癌细胞密度增加。

相似文献

1
Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination.肝内胆管细胞癌的超声造影:与病理检查的相关性。
Br J Radiol. 2012 Aug;85(1016):1029-37. doi: 10.1259/bjr/21653786. Epub 2012 Feb 28.
2
Contrast-enhanced ultrasound appearances of enhancement patterns of intrahepatic cholangiocarcinoma: correlation with pathological findings.肝内胆管细胞癌增强超声表现的增强模式:与病理发现的相关性。
Updates Surg. 2014 Jun;66(2):135-43. doi: 10.1007/s13304-014-0251-6. Epub 2014 May 7.
3
Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.超声造影在鉴别肝细胞癌和胆管细胞癌中的应用。
Ultraschall Med. 2012 Dec;33(7):E191-E195. doi: 10.1055/s-0031-1282029. Epub 2011 Dec 22.
4
Factors Affecting the Enhancement Patterns of Intrahepatic Cholangiocarcinoma (ICC) on Contrast-Enhanced Ultrasound (CEUS) and their Pathological Correlations in Patients with a Single Lesion.单发病灶患者肝内胆管癌(ICC)在超声造影(CEUS)上增强模式的影响因素及其病理相关性
Ultraschall Med. 2016 Dec;37(6):609-618. doi: 10.1055/s-0034-1399485. Epub 2015 Apr 28.
5
Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.动态对比增强超声在非肝硬化肝脏肝细胞癌和肝内胆管细胞癌鉴别诊断中的应用。
Ultrasound Med Biol. 2023 Aug;49(8):1780-1788. doi: 10.1016/j.ultrasmedbio.2023.03.026. Epub 2023 May 6.
6
Characteristics of contrast-enhanced ultrasound in distinguishing small (≤3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma.超声造影在鉴别小(≤3厘米)肝细胞癌与肝内胆管癌中的特征
Medicine (Baltimore). 2018 Oct;97(41):e12781. doi: 10.1097/MD.0000000000012781.
7
Dynamic enhancement pattern of intrahepatic cholangiocarcinoma on contrast-enhanced ultrasound: the correlation with cirrhosis and tumor size.肝内胆管癌在超声造影上的动态增强模式:与肝硬化及肿瘤大小的相关性
Abdom Imaging. 2015 Aug;40(6):1558-66. doi: 10.1007/s00261-015-0379-y.
8
Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT.肝内胆管癌的增强模式:超声造影与CT增强扫描的比较
Br J Radiol. 2008 Nov;81(971):881-9. doi: 10.1259/bjr/22318475.
9
Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?增强超声能区分肝内胆管细胞癌和肝细胞癌吗?
World J Gastroenterol. 2020 Jul 21;26(27):3938-3951. doi: 10.3748/wjg.v26.i27.3938.
10
CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.320例肝细胞癌和肝内胆管细胞癌患者的对比增强超声检查——早期或晚期洗脱的重要性:DEGUM多中心试验的亚分析
Ultraschall Med. 2015 Apr;36(2):132-9. doi: 10.1055/s-0034-1399147. Epub 2015 Mar 26.

引用本文的文献

1
Evaluation of combined hepatocellular-cholangiocarcinoma using CEUS LI-RADS: correlation with pathological characteristics.使用CEUS LI-RADS对肝内胆管癌-肝细胞癌混合型进行评估:与病理特征的相关性
Abdom Radiol (NY). 2025 Feb;50(2):646-655. doi: 10.1007/s00261-024-04519-x. Epub 2024 Aug 16.
2
Current and Future Therapeutic Targets for Directed Molecular Therapies in Cholangiocarcinoma.胆管癌定向分子疗法的当前及未来治疗靶点
Cancers (Basel). 2024 Apr 26;16(9):1690. doi: 10.3390/cancers16091690.
3
Diagnosis of intrahepatic cholangiocarcinoma with CEUS.超声造影诊断肝内胆管癌
J Ultrason. 2024 Feb 27;24(96):20240005. doi: 10.15557/jou.2024.0005. eCollection 2024 Feb.
4
Comparison contrast-enhanced CT with contrast-enhanced US in diagnosing combined hepatocellular-cholangiocarcinoma: a propensity score-matched study.对比增强CT与对比增强超声在诊断肝细胞胆管癌中的对比:一项倾向评分匹配研究。
Insights Imaging. 2024 Feb 14;15(1):44. doi: 10.1186/s13244-023-01576-6.
5
A multi-parameter intrahepatic cholangiocarcinoma scoring system based on modified contrast-enhanced ultrasound LI-RADS M criteria for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.基于改良对比增强超声 LI-RADS M 标准的多参数肝内胆管细胞癌评分系统,用于鉴别肝内胆管细胞癌与肝细胞癌。
Abdom Radiol (NY). 2024 Feb;49(2):458-470. doi: 10.1007/s00261-023-04114-6. Epub 2024 Jan 16.
6
A nomogram based on ultrasonographic features and clinical indicators for differentiating mass-forming intrahepatic cholangiocarcinoma and liver metastatic colorectal adenocarcinoma.基于超声特征和临床指标的列线图用于鉴别肿块型肝内胆管癌和肝转移性结直肠腺癌
Front Oncol. 2023 Oct 31;13:1245686. doi: 10.3389/fonc.2023.1245686. eCollection 2023.
7
Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives.对比增强成像在肝内胆管癌管理中的应用:现状与未来展望
Cancers (Basel). 2023 Jun 28;15(13):3393. doi: 10.3390/cancers15133393.
8
Contrast-enhanced ultrasound manifestations of synchronous combined hepatocellular-cholangiocarcinoma and hepatocellular carcinoma: A case report.同步性肝细胞胆管癌与肝细胞癌的超声造影表现:一例报告
World J Clin Cases. 2022 Apr 16;10(11):3615-3623. doi: 10.12998/wjcc.v10.i11.3615.
9
Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings.肝内胆管细胞癌:发病机制、当前分期和影像学表现。
Abdom Radiol (NY). 2020 Nov;45(11):3662-3680. doi: 10.1007/s00261-020-02559-7.
10
Contrast-enhanced Ultrasound Features of Intrahepatic Cholangiocarcinoma: A New Perspective.肝内胆管癌的超声造影特征:新视角。
Sci Rep. 2019 Dec 18;9(1):19363. doi: 10.1038/s41598-019-55857-6.

本文引用的文献

1
Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.肝硬化患者肝内周围型胆管细胞癌在超声造影上可能表现出类似于肝细胞癌的血管模式。
Hepatology. 2010 Jun;51(6):2020-9. doi: 10.1002/hep.23600.
2
Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound.肝内胆管细胞癌和肝细胞癌:超声造影的鉴别诊断。
Eur Radiol. 2010 Mar;20(3):743-53. doi: 10.1007/s00330-009-1599-8. Epub 2009 Sep 4.
3
Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT.肝内胆管癌的增强模式:超声造影与CT增强扫描的比较
Br J Radiol. 2008 Nov;81(971):881-9. doi: 10.1259/bjr/22318475.
4
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008.超声造影(CEUS)指南及临床实践建议 - 2008年更新版
Ultraschall Med. 2008 Feb;29(1):28-44. doi: 10.1055/s-2007-963785.
5
Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent.使用低机械指数模式和六氟化硫填充微泡造影剂的超声造影对肝脏局灶性病变进行特征分析。
J Clin Ultrasound. 2006 Jul-Aug;34(6):261-72. doi: 10.1002/jcu.20234.
6
Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience.低机械指数超声造影联合声诺维在外周胆管癌成像中的应用:初步经验
J Ultrasound Med. 2006 Jan;25(1):23-33. doi: 10.7863/jum.2006.25.1.23.
7
Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma.延迟期动态CT增强作为肿块型肝内胆管癌的预后因素
Radiology. 2006 Jan;238(1):150-5. doi: 10.1148/radiol.2381041765. Epub 2005 Nov 22.
8
Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.硬化型肝细胞癌的细胞和基质特征:与肝细胞癌及肝内胆管癌的比较
Pathol Int. 2005 Nov;55(11):724-31. doi: 10.1111/j.1440-1827.2005.01891.x.
9
Management of hepatocellular carcinoma.肝细胞癌的管理
Hepatology. 2005 Nov;42(5):1208-36. doi: 10.1002/hep.20933.
10
Cholangiocarcinoma.胆管癌
Lancet. 2005 Oct 8;366(9493):1303-14. doi: 10.1016/S0140-6736(05)67530-7.